Amedeo Smart

Free Medical Literature Service



Alzheimer's Disease

  Free Subscription

Articles published in
BMC Neurol
    September 2022
  1. GAN J, Chen Z, Liu S, Shi Z, et al
    The presence and co-incidence of geriatric syndromes in older patients with mild-moderate Lewy body dementia.
    BMC Neurol. 2022;22:355.
    >> Share

    July 2022
  2. ALTY J, Bai Q, Li R, Lawler K, et al
    The TAS Test project: a prospective longitudinal validation of new online motor-cognitive tests to detect preclinical Alzheimer's disease and estimate 5-year risks of cognitive decline and dementia.
    BMC Neurol. 2022;22:266.
    >> Share

    June 2022
  3. GUO M, Jia J, Zhang J, Zhou M, et al
    Association of beta-cell function and cognitive impairment in patients with abnormal glucose metabolism.
    BMC Neurol. 2022;22:232.
    >> Share

  4. HE L, Chen Z, Wang J, Feng H, et al
    Expression relationship and significance of NEAT1 and miR-27a-3p in serum and cerebrospinal fluid of patients with Alzheimer's disease.
    BMC Neurol. 2022;22:203.
    >> Share

    May 2022
  5. XIA P, Chen J, Bai X, Li M, et al
    Key gene network related to primary ciliary dyskinesia in hippocampus of patients with Alzheimer's disease revealed by weighted gene co-expression network analysis.
    BMC Neurol. 2022;22:198.
    >> Share

    March 2022
  6. KHADHRAOUI E, Muller SJ, Hansen N, Riedel CH, et al
    Manual and automated analysis of atrophy patterns in dementia with Lewy bodies on MRI.
    BMC Neurol. 2022;22:114.
    >> Share

  7. HANSEN S, Keune J, Kufner K, Meister R, et al
    The congruency of neuropsychological and F18-FDG brain PET/CT diagnostics of Alzheimer's Disease (AD) in routine clinical practice: insights from a mixed neurological patient cohort.
    BMC Neurol. 2022;22:83.
    >> Share

    February 2022
  8. LIU Y, Tan MS, Wang ZT, Xu W, et al
    Caspase-1 variant influencing CSF tau and FDG PET levels in non-demented elders from the ADNI cohort.
    BMC Neurol. 2022;22:59.
    >> Share

    January 2022
  9. LIU R, Tang S, Wang Y, Dong Y, et al
    Self-reported sleep characteristics associated with dementia among rural-dwelling Chinese older adults: a population-based study.
    BMC Neurol. 2022;22:5.
    >> Share

    November 2021
  10. YANG XY, Hou XH, Bi YL, Hu H, et al
    Anaemia and cerebrospinal fluid biomarkers of Alzheimer's pathology in cognitively normal elders: the CABLE study.
    BMC Neurol. 2021;21:454.
    >> Share

  11. STROFFOLINI G, Guastamacchia G, Audagnotto S, Atzori C, et al
    Low cerebrospinal fluid Amyloid-betaeta 1-42 in patients with tuberculous meningitis.
    BMC Neurol. 2021;21:449.
    >> Share

    October 2021
  12. ZHU W, Li X, Li X, Wang H, et al
    The protective impact of education on brain structure and function in Alzheimer's disease.
    BMC Neurol. 2021;21:423.
    >> Share

  13. ZHAO LJ, Wang ZT, Ma YH, Zhang W, et al
    Associations of the cerebrospinal fluid hepatocyte growth factor with Alzheimer's disease pathology and cognitive function.
    BMC Neurol. 2021;21:387.
    >> Share

  14. WANG XL, Li L
    Cell type-specific potential pathogenic genes and functional pathways in Alzheimer's Disease.
    BMC Neurol. 2021;21:381.
    >> Share

    August 2021
  15. AXENHUS M, Bogdanovic N
    Confusion, cognitive impairment, and spinal cord compression caused by plasmacytoma: a case report.
    BMC Neurol. 2021;21:303.
    >> Share

    July 2021
  16. MOLINDER A, Ziegelitz D, Maier SE, Eckerstrom C, et al
    Validity and reliability of the medial temporal lobe atrophy scale in a memory clinic population.
    BMC Neurol. 2021;21:289.
    >> Share

  17. WANG L, Li P, Hou M, Zhang X, et al
    Construction of a risk prediction model for Alzheimer's disease in the elderly population.
    BMC Neurol. 2021;21:271.
    >> Share

    May 2021
  18. STROEHLEIN JK, Vieluf S, Zimmer P, Schenk A, et al
    Learning to play golf for elderly people with subjective memory complaints: feasibility of a single-blinded randomized pilot trial.
    BMC Neurol. 2021;21:200.
    >> Share

    April 2021
  19. QIAN S, Chen K, Guan Q, Guo Q, et al
    Performance of Mattis dementia rating scale-Chinese version in patients with mild cognitive impairment and Alzheimer's disease.
    BMC Neurol. 2021;21:172.
    >> Share

    February 2021
  20. SHIMURA H, Saiko A, Hayashi A, Hattori N, et al
    Rivastigmine improves dual-task gait velocity in patients with Alzheimer's disease.
    BMC Neurol. 2021;21:61.
    >> Share

    November 2020
  21. OSAWA A, Maeshima S, Arai H, Kondo I, et al
    Dementia with aphasia and mirror phenomenon: examination of the mechanism using neuroimaging and neuropsychological findings: a case report.
    BMC Neurol. 2020;20:425.
    >> Share

  22. YU SY, Lian TH, Guo P, Li LX, et al
    Correlations of apathy with clinical symptoms of Alzheimer's disease and olfactory dysfunctions: a cross-sectional study.
    BMC Neurol. 2020;20:416.
    >> Share

    October 2020
  23. LEE P, Kim HR, Jeong Y
    Detection of gray matter microstructural changes in Alzheimer's disease continuum using fiber orientation.
    BMC Neurol. 2020;20:362.
    >> Share

    August 2020
  24. PEARSON A, Ajoy R, Crynen G, Reed JM, et al
    Molecular abnormalities in autopsied brain tissue from the inferior horn of the lateral ventricles of nonagenarians and Alzheimer disease patients.
    BMC Neurol. 2020;20:317.
    >> Share

    June 2020
  25. PARK KS, Ganesh AB, Berry NT, Mobley YP, et al
    The effect of physical activity on cognition relative to APOE genotype (PAAD-2): study protocol for a phase II randomized control trial.
    BMC Neurol. 2020;20:231.
    >> Share

    May 2020
  26. MIMURA Y, Kurose S, Takata T, Tabuchi H, et al
    Pisa syndrome induced by switching of a choline-esterase inhibitor treatment from donepezil to galantamine: a case report.
    BMC Neurol. 2020;20:183.
    >> Share

    April 2020
  27. TENG L, Li Y, Zhao Y, Hu T, et al
    Predicting MCI progression with FDG-PET and cognitive scores: a longitudinal study.
    BMC Neurol. 2020;20:148.
    >> Share

    March 2020
  28. KOUZUKI M, Ichikawa J, Shirasagi D, Katsube F, et al
    Detection and recognition thresholds for five basic tastes in patients with mild cognitive impairment and Alzheimer's disease dementia.
    BMC Neurol. 2020;20:110.
    >> Share

  29. ORTNER M, Drost R, Hedderich D, Goldhardt O, et al
    Correction to: Amyloid PET, FDG-PET or MRI? - the power of different imaging biomarkers to detect progression of early Alzheimer's disease.
    BMC Neurol. 2020;20:80.
    >> Share

    January 2020
  30. WATTMO C, Blennow K, Hansson O
    Cerebro-spinal fluid biomarker levels: phosphorylated tau (T) and total tau (N) as markers for rate of progression in Alzheimer's disease.
    BMC Neurol. 2020;20:10.
    >> Share

    December 2019
  31. FEIS RA, Bouts MJRJ, Dopper EGP, Filippini N, et al
    Multimodal MRI of grey matter, white matter, and functional connectivity in cognitively healthy mutation carriers at risk for frontotemporal dementia and Alzheimer's disease.
    BMC Neurol. 2019;19:343.
    >> Share

    November 2019
  32. CHAI B, Gao F, Wu R, Dong T, et al
    Vitamin D deficiency as a risk factor for dementia and Alzheimer's disease: an updated meta-analysis.
    BMC Neurol. 2019;19:284.
    >> Share

  33. ZHANG YR, Ding YL, Chen KL, Liu Y, et al
    The items in the Chinese version of the Montreal cognitive assessment basic discriminate among different severities of Alzheimer's disease.
    BMC Neurol. 2019;19:269.
    >> Share

    October 2019
  34. ORTNER M, Drost R, Heddderich D, Goldhardt O, et al
    Amyloid PET, FDG-PET or MRI? - the power of different imaging biomarkers to detect progression of early Alzheimer's disease.
    BMC Neurol. 2019;19:264.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016